|
C7ORF59 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.85019999998648E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.53793999999596E-05 |
| Normal-vs-Stage2 |
1.103150E-01 |
| Normal-vs-Stage3 |
6.222000E-01 |
| Normal-vs-Stage4 |
1.244210E-01 |
| Stage1-vs-Stage2 |
1.546440E-01 |
| Stage1-vs-Stage3 |
1.025790E-02 |
| Stage1-vs-Stage4 |
8.379200E-01 |
| Stage2-vs-Stage3 |
3.592600E-01 |
| Stage2-vs-Stage4 |
5.139600E-01 |
| Stage3-vs-Stage4 |
1.843990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.77630000000695E-06 |
| Normal-vs-AfricanAmerican |
7.402600E-03 |
| Normal-vs-Asian |
1.266430E-01 |
| Caucasian-vs-AfricanAmerican |
9.539000E-01 |
| Caucasian-vs-Asian |
6.657600E-01 |
| AfricanAmerican-vs-Asian |
7.209200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.06410000039392E-07 |
| Normal-vs-Female |
5.416100E-02 |
| Male-vs-Female |
5.608000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.417700E-03 |
| Normal-vs-Extreme_Weight |
1.84290000038168E-07 |
| Normal-vs-Obese |
1.387930E-02 |
| Normal-vs-Extreme_Obese |
1.042370E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.335600E-01 |
| Normal_Weight-vs-Obese |
9.948200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.417800E-01 |
| Extreme_Weight-vs-Obese |
4.076800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.589550E-01 |
| Obese-vs-Extreme_Obese |
3.653000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.230370E-01 |
| Normal-vs-Age(41-60Yrs) |
8.972400E-04 |
| Normal-vs-Age(61-80Yrs) |
4.19350000002705E-06 |
| Normal-vs-Age(81-100Yrs) |
1.906000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.532200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.001600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.058400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.972500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.546800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.385800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.87969989468218E-10 |
| Normal-VS-Type2 PRCC |
1.743360E-01 |
| Normal-VS-KIRP CIMP |
2.297200E-01 |
| Normal-VS-Unclassified PRCC |
4.906600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.43470000000201E-05 |
| Type1 PRCC-VS-KIRP CIMP |
3.54559999999893E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
3.55239999971779E-07 |
| Type2 PRCC-VS-KIRP CIMP |
5.657500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.974000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.654960E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.799000E-04 |
| Normal-vs-N1 |
3.272800E-01 |
| Normal-vs-N2 |
1.162330E-02 |
| N0-vs-N1 |
1.501690E-03 |
| N0-vs-N2 |
7.621200E-01 |
| N1-vs-N2 |
3.308200E-02 |
|
|
